Spyre's SPY003 meets primary endpoint in Phase 2 UC trial

Go back to Spyre's SPY003 meets primary endpoint in Phase 2 UC trial
(NASDAQ: SYRE) Delayed: 94.55 +3.15 (3.45%)
Previous Close $91.40    52 Week High $ 
Open $92.78    52 Week Low $ 
Day High $95.17    P/E N/A 
Day Low $92.32    EPS $ 
Volume 242,777